Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells (scholarly article)

Natural killer cell activity in the rat. Analysis of effector cell morphology and effects of interferon on natural killer cell function in the athymic (nude) rat

Q72675934

Effect of interleukin-10 on dendritic cell maturation and function

Q73396250

CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10

Q73509865

Human CD4+ CD25+ regulatory T cells suppress NKT cell functions

Q73784466

MHC class I-Ly49 interactions shape the Ly49 repertoire on murine NK cells

Q73896228

Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells

Q74244102

Critical role of NK but not NKT cells in acute rejection of parental bone marrow cells in F1 hybrid mice

Q77357383

The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality

Q78033315

Donor CD4+CD25+ T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation

Q80884347

Lack of correlation between an assay used to determine early marrow allograft rejection and long-term chimerism after murine allogeneic bone marrow transplantation: effects of marrow dose

Q81616857

Control of regulatory T cell development by the transcription factor Foxp3

Q27860489

Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases

Q28131652

CD4+CD25+ Immunoregulatory T Cells Suppress Polyclonal T Cell Activation In Vitro by Inhibiting Interleukin 2 Production

Q29619536

Biology of natural killer cells

Q29619728

Increased bone marrow allograft rejection by depletion of NK cells expressing inhibitory Ly49 NK receptors for donor class I antigens

Q30857349

Interleukin-2-activated natural killer cells can support hematopoiesis in vitro and promote marrow engraftment in vivo

Q31170922

Natural killer cells in antiviral defense: function and regulation by innate cytokines

Q33652468

Regulatory T cells in autoimmmunity*.

Q33904108

Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion

Q33932451

Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts

Q34313946

Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.

Q34509694

Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta

Q34517421

Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells.

Q34529123

An absence of T cells in murine bone marrow allografts leads to an increased susceptibility to rejection by natural killer cells and T cells

Q34537673

Adjuvants and the promotion of Th1-type cytokines in tumour immunotherapy

Q34971986

Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation

Q35279873

Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F 1 hybrid mice

Q36271368

Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection

Q36353538

Immunoregulatory role of transforming growth factor beta (TGF-beta) in development of killer cells: comparison of active and latent TGF-beta 1

Q36354197

Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation

Q36370863

CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner

Q36403637

Rapid rejection of H2k and H2k/b bone marrow cell grafts by CD8+ T cells and NK cells in irradiated mice

Q36681966

Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation

Q37381313

CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer

Q40327394

Modulation of monocyte/macrophage function by human CD4+CD25+ regulatory T cells

Q41895496

Reciprocal activating interaction between natural killer cells and dendritic cells

Q41992239

Differential natural killer cell reactivity against T cell lymphomas by cells from normal or stimulated mice.

Q43796801

A role for transforming growth factor-beta 1 in regulating natural killer cell and T lymphocyte proliferative responses during acute infection with lymphocytic choriomeningitis virus

Q45854203

Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients

Q47371541

Antagonistic effect of NK cells on alternatively activated monocytes: a contribution of NK cells to CTL generation

Q52009896

CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses

Q56904642

Induction of tumor-specific T cell memory by NK cell–mediated tumor rejection

Q60489553

Human lymphokine activated killer (LAK) cells suppress generation of allospecific cytotoxic T cells: implications for use of LAK cells to prevent graft-versus-host disease in allogeneic bone marrow transplantation

Q67894729

Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer

Q71601446

Regulation of NK cell functions by TGF-beta 1

Q71960986

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

bone marrow

Q546523

P304

page(s)

5460-5465

P577

publication date

2006-03-27

P1433

published in

Proceedings of the National Academy of Sciences of the United States of America

Q1146531

P1476

title

Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells

P478

volume

103

Reverse relations

cites work (P2860)

Q36449146	Activated mouse CD4+Foxp3− T cells facilitate melanoma metastasis via Qa-1-dependent suppression of NK-cell cytotoxicity
Q33912853	Adaptive control of innate immunity
Q39161011	Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy
Q33850138	Allogeneic natural killer cells for refractory lymphoma
Q84086506	Altered natural killer (NK) cell frequency and phenotype in latent autoimmune diabetes in adults (LADA) prior to insulin deficiency
Q36279520	Association of peripheral NK cell counts with Helios+ IFN-γ- Tregs in patients with good long-term renal allograft function.
Q37234615	Bortezomib treatment and regulatory T-cell depletion enhance the antitumor effects of adoptively infused NK cells
Q37346143	Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells.
Q41677003	CD4+CD25+ Regulatory T Cells Inhibit Natural Killer Cell Hepatocytotoxicity of Hepatitis B Virus Transgenic Mice via Membrane-Bound TGF-β and OX40.
Q88493595	Changes of NK cell subsets with time post-transplant in peripheral blood of renal transplant recipients
Q37327064	Combination therapy using IL-2 and anti-CD25 results in augmented natural killer cell-mediated antitumor responses
Q38155240	Current and future approaches to treat graft failure after allogeneic hematopoietic stem cell transplantation
Q41667279	Defective STAT1 activation associated with impaired IFN-γ production in NK and T lymphocytes from metastatic melanoma patients treated with IL-2.
Q42952291	Depletion of T regulatory cells promotes natural killer cell-mediated cardiac allograft vasculopathy
Q79829285	Donor double-negative Treg promote allogeneic mixed chimerism and tolerance
Q47844461	Double negative Treg cells promote nonmyeloablative bone marrow chimerism by inducing T‐cell clonal deletion and suppressing NK cell function
Q36668089	Evidence That FoxP3+ Regulatory T Cells May Play a Role in Promoting Long-Term Acceptance of Composite Tissue Allotransplants
Q56899556	Foxp3-transduced polyclonal regulatory T cells suppress NK cell functions in a TGF-beta dependent manner
Q88560885	Graft failure after allogeneic hematopoietic stem cell transplantation
Q33931910	Hematopoietic progenitor cell regulation by CD4+CD25+ T cells
Q37066280	Host CD4+CD25+ T cells can expand and comprise a major component of the Treg compartment after experimental HCT
Q39476748	Human tumor-induced and naturally occurring Treg cells differentially affect NK cells activated by either IL-2 or target cells
Q36423437	Hydrodynamic delivery of human IL-15 cDNA increases murine natural killer cell recovery after syngeneic bone marrow transplantation
Q34651540	IL-2-dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells
Q28078949	Immunological Basis of Bone Marrow Failure after Allogeneic Hematopoietic Stem Cell Transplantation
Q34563034	Increased antitumor effects using IL-2 with anti-TGF-β reveals competition between mouse NK and CD8 T cells.
Q89965556	Indirect Impact of PD-1/PD-L1 Blockade on a Murine Model of NK Cell Exhaustion
Q37000445	Inhibition of lung metastasis by chemokine CCL17-mediated in vivo silencing of genes in CCR4+ Tregs
Q27008625	Interaction between natural killer cells and regulatory T cells: perspectives for immunotherapy
Q38240762	Interactions between innate and adaptive lymphocytes.
Q37178190	Intraperitoneal delivery of human natural killer cells for treatment of ovarian cancer in a mouse xenograft model.
Q35887296	Mouse host unlicensed NK cells promote donor allogeneic bone marrow engraftment.
Q36820198	Murine natural killer cell licensing and regulation by T regulatory cells in viral responses
Q26765845	NK Cell and CD4+FoxP3+ Regulatory T Cell Based Therapies for Hematopoietic Stem Cell Engraftment
Q37315670	NK cells and Treg cells: a fascinating dance cheek to cheek
Q35915642	NK-dependent increases in CCL22 secretion selectively recruits regulatory T cells to the tumor microenvironment
Q38362633	NKp44 and Natural Cytotoxicity Receptors as Damage-Associated Molecular Pattern Recognition Receptors
Q38117142	Natural Killer Cells in Asthma
Q33734571	Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid Leukemia
Q37996816	Natural killer cell immune escape in acute myeloid leukemia.
Q37397516	Natural killer cell tolerance licensing and other mechanisms.
Q37786500	Natural killer cells and tumor control
Q27001081	Neoplastic "Black Ops": cancer's subversive tactics in overcoming host defenses
Q37776637	Pleiotropic effects of transforming growth factor-β in hematopoietic stem-cell transplantation.
Q37256962	Regulation of NK cell responsiveness to achieve self-tolerance and maximal responses to diseased target cells
Q45243164	Regulatory T cells and NK cells in cancer patients
Q35553553	Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation?
Q36692284	Regulatory and conventional CD4+ T cells show differential effects correlating with PD-1 and B7-H1 expression after immunotherapy
Q36518933	Self-tolerance of natural killer cells
Q36907905	T cell regulation of natural killer cells
Q37595721	Targeting Treg cells in situ: emerging expansion strategies for (CD4(+)CD25(+)) regulatory T cells
Q38073762	The TNF receptor-ligands 4-1BB-4-1BBL and GITR-GITRL in NK cell responses
Q37228646	The biology and therapeutic potential of natural regulatory T-cells in the bone marrow transplant setting
Q39561301	The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer
Q33330270	Treg depletion inhibits efficacy of cancer immunotherapy: implications for clinical trials
Q85000659	Treg-based therapy and mixed chimerism in small intestinal transplantation: Does Treg+BMT equal intestine allograft tolerance?
Q37389994	Tumor-derived TGF-beta mediates conversion of CD4+Foxp3+ regulatory T cells in a murine model of pancreas cancer
Q26751011	Underground Adaptation to a Hostile Environment: Acute Myeloid Leukemia vs. Natural Killer Cells
Q37957140	Use of allogeneic NK cells for cancer immunotherapy.

P819	ADS bibcode	2006PNAS..103.5460B
P356	DOI	10.1073/PNAS.0509249103
P8608	Fatcat ID	release_kb7xvggruzfvzlebrqljmtpcxa
P932	PMC publication ID	1459377
P698	PubMed publication ID	16567639
P5875	ResearchGate publication ID	7210950